Outset Medical OM
NASDAQ OM
$3.21 -0.10 (-3.02%)
As of: Sep 10, 2026 · 2:46 PM EDT

Outset Medical (OM) Restructuring Costs (2024)

Outset Medical's (OM) quarterly Restructuring Costs came in at $1.5 million in Q4 2024, up 7.14% quarter-over-quarter from $1.4 million in Q3 2024.

Analysis

Outset Medical (OM) Restructuring Costs (2024) Analysis & Trends

Outset Medical (OM) has reported Restructuring Costs for 1 consecutive years, with $1.5 million the latest figure, recorded in Q4 2024.

  • On a quarterly basis, Restructuring Costs changed N/A year-over-year to $1.5 million in Q4 2024; TTM through Dec 2024 was $5.6 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.5 million, down 40.0% from the prior year.
  • Restructuring Costs was $1.5 million for Q4 2024 at Outset Medical, up from $1.4 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $2.7 million in Q1 2024 and troughed at $1.4 million in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 180.76 Bn 175.16 Bn 7.27 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn
3 Medtronic 117.20 Bn 108.39 Bn 6.34 Bn
4 Stryker 104.01 Bn 100.53 Bn 4.50 Bn
5 Boston Scientific 63.51 Bn 62.97 Bn 3.85 Bn
6 Edwards Lifesciences 49.80 Bn 45.55 Bn 1.35 Bn
7 Alcon 33.03 Bn 31.58 Bn 1.68 Bn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn
10 Outset Medical 59.77 Mn -203.42 Mn 13.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.50 Mn
Sep 30, 2024 1.40 Mn
Mar 31, 2024 2.70 Mn